This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!
Opexa Therapeutics Inc
OPXA : NASDAQ : Health Care
$0.81 | %
Today's Range: 0.78 - 0.85
Avg. Daily Volume: 112,100
12/26/14 - 3:55 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
OPXA OPEXA THERAPEUTICS INC 0.80 22.54 n/m 1.31 43.02
CRMD CORMEDIX INC 1.55 34.69 n/m 0.11 n/a
RXII RXI PHARMACEUTICALS CORP 1.60 33.81 n/m 0.09 -79.03
OGEN ORAGENICS INC 0.90 32.56 n/m 1.15 12.25
PTN PALATIN TECHNOLOGIES INC 0.71 28.04 n/m 4.93 82100.00
XTLB XTL BIOPHARMACEUTICALS 2.21 26.21 n/m 1.97 -12.79
HART HARVARD APPARATUS REGN TECH 3.10 24.36 n/m 0.07 n/a
CYCC CYCLACEL PHARMACEUTICALS 0.69 17.43 n/m 1.79 126.07
DARA DARA BIOSCIENCES INC 0.87 17.04 n/m 1.35 364.26
CBLI CLEVELAND BIOLABS INC 0.28 16.00 n/m 6.18 -8.78
ICCC IMMUCELL CORP 5.00 15.14 n/m 6.95 18.43
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

OPXA Ind Avg S&P 500
n/m 69.32 20.19

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs